EICHORPublic-registry site landscape for NCT04251182, “Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects”, a Alzheimer Disease study sponsored by T3D Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04251182 (registry record) |
| Study title | Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease |
| Sponsor | T3D Therapeutics, Inc. |
| Condition(s) | Alzheimer Disease |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT04251182.
Eichor generates a preliminary site-risk snapshot for NCT04251182 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Alzheimer Disease studies · Weekly briefs
